Global Influenza Diagnostics Industry: Key Statistics and Insights in 2025-2033
Summary:
- The global influenza diagnostics market size reached USD 1,014.3 Million in 2024.
- The market is expected to reach USD 1,614.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.15% during 2025-2033.
- North America leads the market, accounting for the largest influenza diagnostics market share.
- The trend towards molecular diagnostic techniques is growing. These include PCR and NAATs. Their high sensitivity and specificity fuel this growth. They can detect multiple influenza strains at once.
- The demand for fast, easy POC diagnostics is rising. This is boosting the use of point-of-care testing (POCT) devices. They allow for quick diagnoses and better treatment decisions.
- Multiplex diagnostic tests are becoming more popular. They can detect multiple respiratory pathogens and influenza viruses at once. This makes testing more efficient.
- Advanced diagnostic techniques are key to better infection control. They allow for faster identification of respiratory infections. By streamlining testing, multiplex assays help manage respiratory infections. This improves patient outcomes.
Industry Trends and Drivers:
- Increasing Incidences of Influenza:
The demand for diagnostic testing is expanding in tandem with the incidence of influenza. To quickly identify influenza illnesses and enable proper treatment and infection control measures, healthcare practitioners require precise and effective diagnostic technologies. For influenza to be effectively managed and controlled, prompt diagnosis is crucial. As cases rise, early detection is becoming more and more important in order to start the right therapy as soon as possible, lessen the intensity of symptoms, and avoid complications. The use of influenza diagnostic tests is being driven by this.
- Technological Advancements:
Innovations are improving tests for identifying influenza viruses. They will have higher sensitivity and specificity. Nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR), two sophisticated molecular techniques, have excellent sensitivity and can reliably distinguish between influenza virus strains, including seasonal and new forms. Point-of-care (POC) testing is being revolutionized by the introduction of rapid influenza diagnostic tests (RIDTs), which yield results in a matter of minutes. These tests use advanced technology, like molecular assays or lateral flow immunoassays. They identify influenza antigens or viral RNA. This allows for quick diagnosis and treatment.
- Increasing Awareness and Screening Programs:
Increasing awareness initiatives educate people about the signs and symptoms of influenza and encourage them to seek medical assistance as soon as they experience flu-like symptoms. This increased awareness leads to more frequent consultations with healthcare practitioners for diagnostic testing, driving up demand for influenza diagnostics. Awareness campaigns emphasize the significance of early detection and treatment of influenza in order to avoid complications and limit the virus's spread.
Grab a sample PDF of this report: https://www.imarcgroup.com/influenza-diagnostics-market/requestsample
Influenza Diagnostics Market Report Segmentation:
By Product:
- Test Kit and Reagents
- Instruments
- Others
Test kit and reagents represent the largest segment due to their necessity for conducting influenza diagnostics efficiently and accurately.
By Test Type:
- Molecular Diagnostic Tests
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Tests
- Other Molecular Tests
- Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Direct Fluorescent Antibody Test
- Serological Tests
Traditional diagnostic tests account for the majority of the market share owing to their accessibility, cost-effectiveness, and established diagnostic protocols.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the influenza diagnostics market on account of advanced healthcare infrastructure, high awareness levels, extensive research activities, and favorable regulatory policies.
Top Influenza Diagnostics Market Leaders:
The influenza diagnostics market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- Abbott Laboratories
- Becton Dickinson and Company
- Coris Bioconcept
- Danaher Corporation
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd (Roche Holding AG)
- Hologic Inc.
- Meridian Bioscience Inc.
- Qiagen N.V
- Quidel Corporation
- Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
- Siemens Healthineers AG (Siemens AG)
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
